| Total | Intervention | Control | |||
---|---|---|---|---|---|---|
n | %a | n | %a | n | %a | |
Gender (n = 132) | ||||||
 Female | 52 | 39.4 | 16 | 36.4 | 36 | 40.9 |
 Male | 80 | 60.6 | 28 | 63.6 | 52 | 59.1 |
Age (n = 132) | ||||||
 18–24 | 13 | 9.8 | 4 | 9.1 | 9 | 10.2 |
 25–34 | 41 | 31.1 | 12 | 27.3 | 29 | 33.0 |
 35–44 | 32 | 24.2 | 12 | 27.3 | 20 | 22.7 |
 45–54 | 30 | 22.7 | 12 | 27.3 | 18 | 20.5 |
 55+ | 16 | 12.1 | 4 | 9.1 | 12 | 13.6 |
Marital status (n = 132) | ||||||
 Not-married | 66 | 50.0 | 21 | 47.7 | 45 | 51.1 |
 Married | 66 | 50.0 | 23 | 52.3 | 43 | 48.9 |
Education (n = 132) | ||||||
 Secondary school and below | 30 | 22.7 | 6 | 13.6 | 24 | 27.3 |
 High school and above | 102 | 77.3 | 38 | 86.4 | 64 | 72.7 |
Social class (n = 117) | ||||||
 Unemployed | 11 | 9.4 | 1 | 2.6 | 10 | 12.8 |
 Blue collar | 52 | 44.4 | 14 | 35.9 | 38 | 48.7 |
 White collar | 50 | 42.7 | 22 | 56.4 | 28 | 35.9 |
 Self employed | 4 | 3.4 | 2 | 5.1 | 2 | 2.6 |
Daily cigarette consumption (n = 132) | ||||||
  ≤ 10 | 14 | 10.6 | 2 | 4.5 | 12 | 13.6 |
 11–20 | 64 | 48.5 | 22 | 50.0 | 42 | 47.7 |
 21–30 | 32 | 24.2 | 14 | 31.8 | 18 | 20.5 |
  > 30 | 22 | 16.7 | 6 | 13.6 | 16 | 18.2 |
Pack-years (n = 128) | ||||||
  ≤ 10 | 39 | 30.5 | 14 | 32.6 | 25 | 29.4 |
 11–20 | 42 | 32.8 | 15 | 34.9 | 27 | 31.8 |
  > 20 | 47 | 36.7 | 14 | 32.6 | 33 | 38.8 |
Quit attempts (n = 132) | ||||||
 Yes | 23 | 17.4 | 6 | 13.6 | 17 | 19.3 |
 No | 109 | 82.6 | 38 | 86.4 | 71 | 80.7 |
Nicotine dependence level (n = 132) | ||||||
 Low | 14 | 10.6 | 3 | 6.8 | 11 | 12.5 |
 Medium | 89 | 67.4 | 30 | 68.2 | 59 | 67.0 |
 High | 29 | 22.0 | 11 | 25 | 18 | 20.5 |
Depression score (n = 130) | ||||||
 Normal | 83 | 63.8 | 29 | 67.4 | 54 | 62.1 |
 High | 47 | 36.2 | 14 | 32.6 | 33 | 37.9 |
CO value (n = 132) | ||||||
 0–6 | 13 | 9.8 | 4 | 9.1 | 9 | 10.2 |
 7–10 | 12 | 9.1 | 3 | 6.8 | 9 | 10.2 |
  > 10 | 107 | 81.1 | 37 | 84.1 | 70 | 79.5 |
Concomitant disease (n = 132) | ||||||
 No | 31 | 23.5 | 9 | 20.5 | 22 | 25 |
 Yes | 101 | 76.5 | 35 | 79.5 | 66 | 75 |
Consulting physicians (n = 132) | ||||||
 A | 27 | 20.5 | 9 | 20.5 | 18 | 20.5 |
 B | 19 | 14.4 | 9 | 20.5 | 10 | 11.4 |
 C | 26 | 19.7 | 8 | 18.2 | 18 | 20.5 |
 D | 30 | 22.7 | 9 | 20.5 | 21 | 23.9 |
 E | 30 | 22.7 | 9 | 20.5 | 21 | 23.9 |
Pharmacotherapy (n = 131) | ||||||
 NRT | 48 | 36.6 | 9 | 20.9 | 39 | 44.3 |
 Bupropion | 22 | 16.8 | 9 | 20.9 | 13 | 14.8 |
 Varenicline | 13 | 9.9 | 4 | 9.3 | 9 | 10.2 |
 Combinedb | 48 | 36.6 | 21 | 36.6 | 27 | 30.7 |